Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter
- PMID: 14645737
- DOI: 10.1152/physiolgenomics.00087.2001
Molecular signature of late-stage human ALS revealed by expression profiling of postmortem spinal cord gray matter
Abstract
Little is known about global gene expression patterns in the human neurodegenerative disease amyotrophic lateral sclerosis (ALS). To address this, we used high-density oligonucleotide microarray technology to compare expression levels of approximately 6,800 genes in postmortem spinal cord gray matter obtained from individuals with ALS as well as normal individuals. Using Fisher discriminant analysis (FDA) and leave-one-out cross-validation (LOOCV), we discerned an ALS-specific signature. Moreover, it was possible to distinguish familial ALS (FALS) from sporadic ALS (SALS) gene expression profiles. Characterization of the specific genes significantly altered in ALS uncovered a pro-inflammatory terminal state. Moreover, we found alterations in genes involved in mitochondrial function, oxidative stress, excitotoxicity, apoptosis, cytoskeletal architecture, RNA transcription and translation, proteasomal function, and growth and signaling. It is apparent from this study that DNA microarray analysis and appropriate bioinformatics can reveal distinct phenotypic changes that underlie the terminal stages of neurodegeneration in ALS.
Similar articles
-
Focal dysfunction of the proteasome: a pathogenic factor in a mouse model of amyotrophic lateral sclerosis.J Neurochem. 2004 Jun;89(6):1325-35. doi: 10.1111/j.1471-4159.2004.02453.x. J Neurochem. 2004. PMID: 15189335
-
Discrete mitochondrial aberrations in the spinal cord of sporadic ALS patients.J Neurosci Res. 2018 Aug;96(8):1353-1366. doi: 10.1002/jnr.24249. Epub 2018 May 6. J Neurosci Res. 2018. PMID: 29732581
-
Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.Neurobiol Dis. 2001 Dec;8(6):933-41. doi: 10.1006/nbdi.2001.0443. Neurobiol Dis. 2001. PMID: 11741389
-
[Molecular pathogenesis of motor neuron disease].Rinsho Shinkeigaku. 2001 Dec;41(12):1070-1. Rinsho Shinkeigaku. 2001. PMID: 12235798 Review. Japanese.
-
Spinal cord molecular profiling provides a better understanding of amyotrophic lateral sclerosis pathogenesis.Brain Res Brain Res Rev. 2004 Jul;45(3):213-29. doi: 10.1016/j.brainresrev.2004.04.002. Brain Res Brain Res Rev. 2004. PMID: 15210305 Review.
Cited by
-
Integrating Transcriptomic and Structural Insights: Revealing Drug Repurposing Opportunities for Sporadic ALS.ACS Omega. 2024 Jan 10;9(3):3793-3806. doi: 10.1021/acsomega.3c07296. eCollection 2024 Jan 23. ACS Omega. 2024. PMID: 38284068 Free PMC article.
-
Microarrays in Parkinson's disease: a systematic approach.NeuroRx. 2006 Jul;3(3):319-26. doi: 10.1016/j.nurx.2006.05.008. NeuroRx. 2006. PMID: 16815215 Free PMC article. Review.
-
Nuclear Receptors as Therapeutic Targets for Neurodegenerative Diseases: Lost in Translation.Annu Rev Pharmacol Toxicol. 2019 Jan 6;59:237-261. doi: 10.1146/annurev-pharmtox-010818-021807. Epub 2018 Sep 12. Annu Rev Pharmacol Toxicol. 2019. PMID: 30208281 Free PMC article. Review.
-
Deregulated expression of cytoskeleton related genes in the spinal cord and sciatic nerve of presymptomatic SOD1(G93A) Amyotrophic Lateral Sclerosis mouse model.Front Cell Neurosci. 2014 May 26;8:148. doi: 10.3389/fncel.2014.00148. eCollection 2014. Front Cell Neurosci. 2014. PMID: 24904291 Free PMC article.
-
Microarray analysis of the cellular pathways involved in the adaptation to and progression of motor neuron injury in the SOD1 G93A mouse model of familial ALS.J Neurosci. 2007 Aug 22;27(34):9201-19. doi: 10.1523/JNEUROSCI.1470-07.2007. J Neurosci. 2007. PMID: 17715356 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous